Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
Volume 0.22M
Average 0.35M
RNA Total Current Assets
All assets expected to be converted to cash or used up within one year.
Atrium Therapeutics, Inc.NASDAQ: RNA
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets of $285.57M in Q1 FY2026
Q1 FY2026 total current assets was $285.57M.
Context
- Total current assets amounted to 97.7% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 272.85M USD
- Year-over-year change
- —
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 272.85M | — |
Total Current Assets vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Total Current Assets figures are available to compare.
Balance Sheet
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.